Austar Lifesciences Limited
AULSF
$0.07
$0.071,300.00%
OTC PK
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | 1.73M | 1.72M | 709.10K | 712.50K | 405.80K |
| Total Depreciation and Amortization | 1.53M | 1.52M | 1.74M | 1.75M | 1.55M |
| Total Amortization of Deferred Charges | 215.80K | 214.50K | 236.80K | 238.00K | 189.90K |
| Total Other Non-Cash Items | -781.30K | -776.70K | 1.16M | 1.16M | -797.50K |
| Change in Net Operating Assets | -- | -- | 1.67M | 1.68M | -- |
| Cash from Operations | 2.69M | 2.68M | 5.51M | 5.54M | 1.35M |
| Capital Expenditure | -780.20K | -775.60K | -1.04M | -1.04M | -385.20K |
| Sale of Property, Plant, and Equipment | -- | -- | -726.10K | -729.70K | 6.10K |
| Cash Acquisitions | -- | -- | 196.00K | 197.00K | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 589.60K | 586.10K | 1.02M | 1.02M | 1.23M |
| Cash from Investing | -190.60K | -189.50K | -550.50K | -553.20K | 852.70K |
| Total Debt Issued | 78.85M | 78.85M | 80.85M | 80.85M | 70.72M |
| Total Debt Repaid | -94.59M | -94.59M | -99.57M | -99.57M | -94.21M |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -3.36M | -3.36M | -3.94M | -3.94M | -4.51M |
| Cash from Financing | -2.64M | -2.63M | -3.15M | -3.17M | -3.87M |
| Foreign Exchange rate Adjustments | -10.10K | -10.00K | 55.10K | 55.30K | 23.20K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -148.10K | -147.20K | 1.86M | 1.87M | -1.64M |